Legal Representation
Attorney
Hoang-chi Truong
USPTO Deadlines
Next Deadline
1634 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240709)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 9, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 31, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| May 31, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 30, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 28, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 30, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 2, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 2, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 1, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 1, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 1, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 2, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 2, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 2, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 18, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 2, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 28, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 28, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 28, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 28, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 20, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 11, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 14, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Classification
International Classes
042